Sign in
Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Annual Meeting Talks
2019
Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial
Michael S. Ip, MD
Optimization of the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure in the LADDER Phase 2 Trial
Mark R. Wieland, MD
Category: AMD-Neovascular